KLF9 is an evolutionarily well-conserved transcriptional regulator implicated as a tumor/metastasis suppressor in liver [24,25], endometrium [36,37], colon and rectum [38], breast [39], glioblastoma [40], ovary [41], and osteosarcoma [42]. Here, KLF9 is linked to neoplasm.